Literature DB >> 17530177

Pattern of recurrence in paediatric malignant glioma: an institutional experience.

Sucheta J Vaidya1, Darren Hargrave, Frank Saran, Juliet Britton, Rubin Soomal, Eric Bouffet.   

Abstract

BACKGROUND: The purpose of this retrospective study was to investigate the pattern of recurrence in paediatric malignant gliomas.
MATERIAL AND METHODS: We reviewed the notes, diagnostic imaging and treatment charts of 30 consecutive paediatric patients (age less than 18 years at diagnosis, range 0.5-17 years) presenting with a malignant glioma presenting to the paediatric oncology unit at the Royal Marsden Hospital over a 10-year period. The imaging at the time of first relapse was compared with the initial diagnostic scans to define a relapse as local, marginal or distant.
RESULTS: Median follow-up was 13 months (range 1-99 months). Twenty-four of 30 patients (80%) showed evidence of progression with a median time to progression of 8.5 months (range 3-64 months). Thirteen out of 24 patients developed local or marginal recurrences while 11/24 patients recurred at distant sites as site of first relapse (46%).
CONCLUSION: Our series suggests that the pattern of relapses in paediatric malignant gliomas could be different from that reported in adult studies as we observed a significant incidence of distant relapses. Larger prospective series need to be conducted to investigate the clinico-biological characteristics of the population at high risk for leptomeningeal dissemination.

Entities:  

Mesh:

Year:  2007        PMID: 17530177     DOI: 10.1007/s11060-006-9313-z

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.506


  30 in total

1.  Supratentorial malignant gliomas in childhood: a review of fifty cases.

Authors:  E J Dropcho; J H Wisoff; R W Walker; J C Allen
Journal:  Ann Neurol       Date:  1987-09       Impact factor: 10.422

Review 2.  Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review.

Authors:  Normand Laperriere; Lisa Zuraw; Gregory Cairncross
Journal:  Radiother Oncol       Date:  2002-09       Impact factor: 6.280

Review 3.  Patterns of recurrence in brain stem gliomas: evidence for craniospinal dissemination.

Authors:  B Donahue; J Allen; J Siffert; M Rosovsky; R Pinto
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-02-01       Impact factor: 7.038

4.  Prognostic factors for high-grade malignant glioma: development of a prognostic index. A Report of the Medical Research Council Brain Tumour Working Party.

Authors: 
Journal:  J Neurooncol       Date:  1990-08       Impact factor: 4.130

5.  Bihemispheric malignant glioma: one size does not fit all.

Authors:  G S Bauman; B J Fisher; J G Cairncross; D Macdonald
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

6.  High-dose carmustine for high-grade gliomas in childhood.

Authors:  E Bouffet; F Khelfaoui; I Philip; P Biron; M Brunat-Mentigny; T Philip
Journal:  Cancer Chemother Pharmacol       Date:  1997       Impact factor: 3.333

7.  Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

Authors:  W R Shapiro; S B Green; P C Burger; M S Mahaley; R G Selker; J C VanGilder; J T Robertson; J Ransohoff; J Mealey; T A Strike
Journal:  J Neurosurg       Date:  1989-07       Impact factor: 5.115

8.  Leptomeningeal metastasis from supratentorial malignant gliomas.

Authors:  I Awad; J W Bay; L Rogers
Journal:  Neurosurgery       Date:  1986-08       Impact factor: 4.654

9.  Pre-irradiation chemotherapy in children with high-grade astrocytoma: tumor response to two cycles of the '8-drugs-in-1-day' regimen. A Childrens Cancer Group study, CCG-945.

Authors:  J L Finlay; J R Geyer; P A Turski; A J Yates; J M Boyett; J C Allen; R J Packer
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

10.  High-dose multi-agent chemotherapy followed by bone marrow 'rescue' for malignant astrocytomas of childhood and adolescence.

Authors:  J L Finlay; C August; R Packer; R Zimmerman; L Sutton; A Freid; L Rorke; E Bayever; N Kamani; E Kramer
Journal:  J Neurooncol       Date:  1990-12       Impact factor: 4.130

View more
  8 in total

1.  Pediatric supratentorial high-grade glioma: multicenter retrospective observational study of the Korean Society for Pediatric Neuro-Oncology.

Authors:  Tae-Young Jung; Ji Yeoun Lee; Dong-Seok Kim; Hyeon Jin Park; Chae-Yong Kim; Young-Shin Ra; Mee-Jeong Lee; Seong-Ho Kim; Hee-Jo Baek; Il Han Kim; Kyung Duk Park; Seung-Ki Kim
Journal:  J Neurooncol       Date:  2014-11-04       Impact factor: 4.130

2.  Surveillance imaging in children with malignant CNS tumors: low yield of spine MRI.

Authors:  Sébastien Perreault; Robert M Lober; Anne-Sophie Carret; Guohua Zhang; Linda Hershon; Jean-Claude Décarie; Hannes Vogel; Kristen W Yeom; Paul G Fisher; Sonia Partap
Journal:  J Neurooncol       Date:  2014-01-09       Impact factor: 4.130

3.  Patterns of progression in pediatric patients with high-grade glioma or diffuse intrinsic pontine glioma treated with Bevacizumab-based therapy at diagnosis.

Authors:  Ralph Salloum; Mariko DeWire; Adam Lane; Stewart Goldman; Trent Hummel; Lionel Chow; Lili Miles; Mary Sutton; Charles Stevenson; Maryam Fouladi; James Leach
Journal:  J Neurooncol       Date:  2014-11-30       Impact factor: 4.130

4.  Pediatric high-grade glioma: identification of poly(ADP-ribose) polymerase as a potential therapeutic target.

Authors:  Stuart J Smith; Angela Long; Jennifer H Barrow; Donald C Macarthur; Beth Coyle; Richard G Grundy
Journal:  Neuro Oncol       Date:  2011-08-17       Impact factor: 12.300

5.  A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood.

Authors:  Regina I Jakacki; Allan Yates; Susan M Blaney; Tianni Zhou; Robert Timmerman; Ashish M Ingle; Lynda Flom; Michael D Prados; Peter C Adamson; Ian F Pollack
Journal:  Neuro Oncol       Date:  2008-05-22       Impact factor: 12.300

6.  Prognosis of pediatric high-grade gliomas with temozolomide treatment: a retrospective, multicenter study.

Authors:  Tae-Young Jung; Chae-Yong Kim; Dong-Seok Kim; Young-Shin Ra; Seong-Ho Kim; Hee-Jo Baek; Hyoung-Soo Choi; In-Ah Kim
Journal:  Childs Nerv Syst       Date:  2012-05-11       Impact factor: 1.475

7.  CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma.

Authors:  Stuart J Smith; Hanna Tilly; Jennifer H Ward; Donald C Macarthur; James Lowe; Beth Coyle; Richard G Grundy
Journal:  Acta Neuropathol       Date:  2012-02-07       Impact factor: 17.088

8.  A multi-institutional experience in pediatric high-grade glioma.

Authors:  Steve Walston; Daniel A Hamstra; Kevin Oh; Gary Woods; Michael Guiou; Randal S Olshefski; Arnab Chakravarti; Terence M Williams
Journal:  Front Oncol       Date:  2015-02-18       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.